Title	Publication Date	Language	Citations
Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011	2014/12/24	English	339
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)	2017/02/01	English	328
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143	2017/10/28	English	316
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection	2013/12/04	English	314
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma	2010/02/04	English	312
Primary and secondary glioblastomas: From concept to clinical diagnosis	1999/01/01	English	308
Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas	2008/04/01	English	304
Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype	2007/10/01	English	287
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy	2017/03/24	English	279
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma	2017/09/16	English	277
Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study	2010/10/27	English	272
Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades	2013/12/04	English	270
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery	2000/01/01	English	270
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study	2015/01/13	English	269
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma	2008/02/01	English	264
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention	2012/09/01	English	263
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group	2011/02/21	English	253
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma	2009/12/14	English	250
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts	2009/06/01	English	248
A multigene predictor of outcome in glioblastoma	2009/10/20	English	248
"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer	2011/08/24	English	248
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool	2014/01/16	English	246
The molecular profile of microglia under the influence of glioma	2012/05/09	English	242
Immunosuppressive mechanisms in glioblastoma: Fig. 1.	2015/10/29	English	237
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma	2011/06/01	English	237
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma	2010/12/10	English	237
Limitations of stereotactic biopsy in the initial management of gliomas	2001/07/01	English	237
MRI features predict survival and molecular markers in diffuse lower-grade gliomas	2017/01/24	English	237
EANO guideline on the diagnosis and management of meningiomas	2021/06/28	English	228
TGF-  downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients	2009/11/05	English	224